SILVERCREST ASSET MANAGEMENT GROUP LLC - ICU MED INC ownership

ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 292 filers reported holding ICU MED INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
SILVERCREST ASSET MANAGEMENT GROUP LLC ownership history of ICU MED INC
ValueSharesWeighting
Q3 2023$36,313,947
-35.3%
305,134
-3.1%
0.28%
-31.0%
Q2 2023$56,139,897
+13.7%
315,056
+5.3%
0.40%
+6.7%
Q1 2023$49,374,004
+3.5%
299,308
-1.2%
0.38%
+2.2%
Q4 2022$47,691,243
+0.5%
302,840
-3.8%
0.37%
-5.9%
Q3 2022$47,431,000
-1.3%
314,952
+7.7%
0.39%
+6.8%
Q2 2022$48,065,000
-27.6%
292,379
-1.9%
0.36%
-15.3%
Q1 2022$66,350,000
-2.1%
298,019
+3.5%
0.43%
+0.2%
Q4 2021$67,801,000
-11.3%
287,872
-12.1%
0.43%
-16.5%
Q3 2021$76,437,000
+14.2%
327,523
+0.7%
0.52%
+17.3%
Q2 2021$66,917,000
-2.5%
325,153
-2.7%
0.44%
-5.2%
Q1 2021$68,638,000
-13.7%
334,103
-9.9%
0.46%
-20.2%
Q4 2020$79,492,000
+22.7%
370,610
+4.6%
0.58%
+4.3%
Q3 2020$64,768,000
-4.8%
354,388
-4.0%
0.56%
-7.8%
Q2 2020$68,015,000
-5.5%
369,017
+3.5%
0.60%
-21.9%
Q1 2020$71,951,000
+10.2%
356,596
+2.2%
0.77%
+52.6%
Q4 2019$65,269,000
+28.7%
348,812
+9.8%
0.51%
+21.1%
Q3 2019$50,697,000
-9.9%
317,648
+42.2%
0.42%
-20.7%
Q2 2019$56,277,000
+5.0%
223,402
-0.3%
0.53%0.0%
Q1 2019$53,615,000
+1.9%
224,023
-2.2%
0.53%
-9.1%
Q4 2018$52,615,000
-1.0%
229,130
+21.9%
0.58%
+20.3%
Q3 2018$53,126,000
-40.3%
187,891
-38.0%
0.48%
-42.1%
Q2 2018$88,958,000
-2.1%
302,942
-15.9%
0.83%
-6.0%
Q1 2018$90,907,000
+7.1%
360,172
-8.3%
0.89%
+12.3%
Q4 2017$84,855,000
+6.5%
392,848
-8.4%
0.79%
-0.6%
Q3 2017$79,700,000
-4.7%
428,839
-11.6%
0.79%
-11.3%
Q2 2017$83,622,000
-12.8%
484,942
-22.8%
0.90%
-12.8%
Q1 2017$95,882,000
+4.2%
627,910
+0.5%
1.03%
-0.5%
Q4 2016$92,059,000
+19.2%
624,762
+2.1%
1.03%
+11.2%
Q3 2016$77,227,000
+19.0%
611,625
+6.3%
0.93%
+12.4%
Q2 2016$64,894,000
+21.5%
575,561
+12.2%
0.82%
+12.1%
Q1 2016$53,396,000
+5.9%
512,923
+14.8%
0.74%
+5.4%
Q4 2015$50,406,000
+5.8%
446,945
+2.7%
0.70%
-3.7%
Q3 2015$47,647,000
+8.7%
435,131
-5.0%
0.72%
+23.7%
Q2 2015$43,835,000
-2.0%
458,249
-4.6%
0.59%
-7.7%
Q1 2015$44,737,000
+18.1%
480,320
+3.9%
0.64%
+15.7%
Q4 2014$37,867,000
+8.1%
462,353
-15.3%
0.55%
+1.5%
Q3 2014$35,016,000
+17.8%
545,599
+11.6%
0.54%
+21.3%
Q2 2014$29,720,000
+19.2%
488,740
+17.4%
0.45%
+12.3%
Q1 2014$24,934,000
+13.5%
416,408
+20.7%
0.40%
+8.8%
Q4 2013$21,976,000
+32.6%
344,929
+41.4%
0.36%
+14.8%
Q3 2013$16,569,000
-4.6%
243,909
+1.2%
0.32%
-13.4%
Q2 2013$17,371,000241,0720.37%
Other shareholders
ICU MED INC shareholders Q1 2022
NameSharesValueWeighting ↓
NUANCE INVESTMENTS, LLC 1,035,101$212,651,0003.97%
EVR Research LP 22,000$4,520,0003.44%
Tamarack Advisers, LP 70,000$14,381,0002.95%
Nitorum Capital, L.P. 252,668$51,908,0002.56%
PFM Health Sciences, LP 290,661$59,713,0001.82%
KIRR MARBACH & CO LLC /IN/ 22,298$4,581,0001.33%
Findlay Park Partners LLP 671,136$137,878,0000.96%
PURA VIDA INVESTMENTS, LLC 148,548$30,518,0000.87%
Redmile Group, LLC 224,154$46,050,0000.65%
Canvas Wealth Advisors, LLC 5,177$1,064,0000.62%
View complete list of ICU MED INC shareholders